Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Shyamala Maheswaran, Ph.D.

Co-Author

This page shows the publications co-authored by Shyamala Maheswaran and Shannon Stott.
Connection Strength

2.206
  1. Isolation and characterization of circulating tumor cells from patients with localized and metastatic prostate cancer. Sci Transl Med. 2010 Mar 31; 2(25):25ra23.
    View in: PubMed
    Score: 0.460
  2. Tunable nanostructured coating for the capture and selective release of viable circulating tumor cells. . 2015 Mar 04; 27(9):1593-9.
    View in: PubMed
    Score: 0.160
  3. Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis. Cell. 2014 Aug 28; 158(5):1110-1122.
    View in: PubMed
    Score: 0.156
  4. Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science. 2013 Feb 01; 339(6119):580-4.
    View in: PubMed
    Score: 0.140
  5. Isolation of circulating tumor cells using a microvortex-generating herringbone-chip. Proc Natl Acad Sci U S A. 2010 Oct 26; 107(43):18392-7.
    View in: PubMed
    Score: 0.119
  6. The Lipogenic Regulator SREBP2 Induces Transferrin in Circulating Melanoma Cells and Suppresses Ferroptosis. Cancer Discov. 2021 Mar; 11(3):678-695.
    View in: PubMed
    Score: 0.060
  7. Ultrahigh-throughput magnetic sorting of large blood volumes for epitope-agnostic isolation of circulating tumor cells. Proc Natl Acad Sci U S A. 2020 07 21; 117(29):16839-16847.
    View in: PubMed
    Score: 0.059
  8. Microfluidic concentration and separation of circulating tumor cell clusters from large blood volumes. Lab Chip. 2020 02 07; 20(3):558-567.
    View in: PubMed
    Score: 0.057
  9. Ultra-fast vitrification of patient-derived circulating tumor cell lines. PLoS One. 2018; 13(2):e0192734.
    View in: PubMed
    Score: 0.050
  10. An RNA-Based Digital Circulating Tumor Cell Signature Is Predictive of Drug Response and Early Dissemination in Prostate Cancer. Cancer Discov. 2018 03; 8(3):288-303.
    View in: PubMed
    Score: 0.049
  11. Whole blood stabilization for the microfluidic isolation and molecular characterization of circulating tumor cells. Nat Commun. 2017 11 23; 8(1):1733.
    View in: PubMed
    Score: 0.049
  12. Microfluidic isolation of platelet-covered circulating tumor cells. Lab Chip. 2017 10 11; 17(20):3498-3503.
    View in: PubMed
    Score: 0.048
  13. Monolithic Chip for High-throughput Blood Cell Depletion to Sort Rare Circulating Tumor Cells. Sci Rep. 2017 09 07; 7(1):10936.
    View in: PubMed
    Score: 0.048
  14. Clusters of Circulating Tumor Cells: a Biophysical and Technological Perspective. Curr Opin Biomed Eng. 2017 Sep; 3:13-19.
    View in: PubMed
    Score: 0.048
  15. Preservative solution that stabilizes erythrocyte morphology and leukocyte viability under ambient conditions. Sci Rep. 2017 07 18; 7(1):5658.
    View in: PubMed
    Score: 0.048
  16. Microfluidic Isolation of Circulating Tumor Cell Clusters by Size and Asymmetry. Sci Rep. 2017 05 26; 7(1):2433.
    View in: PubMed
    Score: 0.047
  17. Clusters of circulating tumor cells traverse capillary-sized vessels. Proc Natl Acad Sci U S A. 2016 May 03; 113(18):4947-52.
    View in: PubMed
    Score: 0.044
  18. Deformability-based cell selection with downstream immunofluorescence analysis. Integr Biol (Camb). 2016 05 16; 8(5):654-64.
    View in: PubMed
    Score: 0.043
  19. The Role of Physical Stabilization in Whole Blood Preservation. Sci Rep. 2016 Feb 15; 6:21023.
    View in: PubMed
    Score: 0.043
  20. Deformability of Tumor Cells versus Blood Cells. Sci Rep. 2015 Dec 18; 5:18542.
    View in: PubMed
    Score: 0.043
  21. Detection of T790M, the Acquired Resistance EGFR Mutation, by Tumor Biopsy versus Noninvasive Blood-Based Analyses. Clin Cancer Res. 2016 Mar 01; 22(5):1103-10.
    View in: PubMed
    Score: 0.042
  22. Biodegradable nano-films for capture and non-invasive release of circulating tumor cells. Biomaterials. 2015 Oct; 65:93-102.
    View in: PubMed
    Score: 0.041
  23. A microfluidic device for label-free, physical capture of circulating tumor cell clusters. Nat Methods. 2015 Jul; 12(7):685-91.
    View in: PubMed
    Score: 0.041
  24. MAPK7 Regulates EMT Features and Modulates the Generation of CTCs. Mol Cancer Res. 2015 May; 13(5):934-43.
    View in: PubMed
    Score: 0.040
  25. Isolation and molecular characterization of circulating melanoma cells. Cell Rep. 2014 May 08; 7(3):645-53.
    View in: PubMed
    Score: 0.038
  26. Microfluidic, marker-free isolation of circulating tumor cells from blood samples. Nat Protoc. 2014 Mar; 9(3):694-710.
    View in: PubMed
    Score: 0.038
  27. Inertial focusing for tumor antigen-dependent and -independent sorting of rare circulating tumor cells. Sci Transl Med. 2013 Apr 03; 5(179):179ra47.
    View in: PubMed
    Score: 0.035
  28. Androgen receptor signaling in circulating tumor cells as a marker of hormonally responsive prostate cancer. Cancer Discov. 2012 Nov; 2(11):995-1003.
    View in: PubMed
    Score: 0.034
  29. RNA sequencing of pancreatic circulating tumour cells implicates WNT signalling in metastasis. Nature. 2012 Jul 26; 487(7408):510-3.
    View in: PubMed
    Score: 0.034
  30. Biopolymer system for cell recovery from microfluidic cell capture devices. Anal Chem. 2012 Apr 17; 84(8):3682-8.
    View in: PubMed
    Score: 0.033
  31. Circulating tumor cells: approaches to isolation and characterization. J Cell Biol. 2011 Feb 07; 192(3):373-82.
    View in: PubMed
    Score: 0.031
  32. Analyses of circulating tumor cell (CTC) dynamics and treatment response in prostate cancer using the CTC-chip microfluidic device. J Clin Oncol. 2009 May 20; 27(15_suppl):5149.
    View in: PubMed
    Score: 0.027
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.